Bioactive peptides: From basic research to clinical trials and commercialization
At BHRC, all protocols are physician-supervised with baseline health review
The use of the transcriptomic approach has made it possible to study the mechanisms of action of many natural medicinal compounds and peptide drugs successfully used for the treatment of IS [27,28,29]
BPC-157 promotes healing via angiogenesis, nitric oxide balance, and tissue protection, whereas TB-500 primarily enhances cell migration through actin modulation
It remains investigational and has not been approved in any country as of early 2026
In a letter, the FDA confirmed that nominations for several peptides had been withdrawn and that these substances would be removed from Category 2 from April 22